Racial, ethnic and socioeconomic disparities in diagnosis, treatment, and survival of patients with breast cancer.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
01 2023
Historique:
received: 22 02 2022
revised: 07 06 2022
accepted: 14 07 2022
pubmed: 28 8 2022
medline: 20 12 2022
entrez: 27 8 2022
Statut: ppublish

Résumé

The objective of this study was to determine the influence of race/ethnicity and socioeconomic status (SES) on breast cancer outcomes. A retrospective analysis was performed of Non-Hispanic Black (NHB), Non-Hispanic White (NHW), and Hispanic patients with non-metastatic breast cancer in the SEER cancer registry between 2007 and 2016. A total of 382,975 patients were identified. On multivariate analysis, NHB (OR 1.18, 95%CI: 1.15-1.20) and Hispanic (OR 1.20, 95%CI: 1.17-1.22) patients were more likely to present with higher stage disease than NHW patients. There was an increased likelihood of not undergoing breast-reconstruction for NHB (OR 1.07, 95%CI: 1.03-1.11) and Hispanic patients (OR 1.60, 95%CI 1.54-1.66). NHB patients had increased hazard for all-cause mortality (HR: 1.13, 95%CI 1.10-1.16). All-cause mortality increased across SES categories (lower SES: HR 1.33, 95%CI 1.30-1.37, middle SES: HR 1.20, 95%CI 1.17-1.23). This population-based analysis confirms worse disease presentation, access to surgical therapy, and survival across racial, ethnic, and socioeconomic factors. These disparities were compounded across worsening SES and insurance coverage.

Sections du résumé

BACKGROUND
The objective of this study was to determine the influence of race/ethnicity and socioeconomic status (SES) on breast cancer outcomes.
METHODS
A retrospective analysis was performed of Non-Hispanic Black (NHB), Non-Hispanic White (NHW), and Hispanic patients with non-metastatic breast cancer in the SEER cancer registry between 2007 and 2016.
RESULTS
A total of 382,975 patients were identified. On multivariate analysis, NHB (OR 1.18, 95%CI: 1.15-1.20) and Hispanic (OR 1.20, 95%CI: 1.17-1.22) patients were more likely to present with higher stage disease than NHW patients. There was an increased likelihood of not undergoing breast-reconstruction for NHB (OR 1.07, 95%CI: 1.03-1.11) and Hispanic patients (OR 1.60, 95%CI 1.54-1.66). NHB patients had increased hazard for all-cause mortality (HR: 1.13, 95%CI 1.10-1.16). All-cause mortality increased across SES categories (lower SES: HR 1.33, 95%CI 1.30-1.37, middle SES: HR 1.20, 95%CI 1.17-1.23).
CONCLUSIONS
This population-based analysis confirms worse disease presentation, access to surgical therapy, and survival across racial, ethnic, and socioeconomic factors. These disparities were compounded across worsening SES and insurance coverage.

Identifiants

pubmed: 36030101
pii: S0002-9610(22)00448-2
doi: 10.1016/j.amjsurg.2022.07.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-161

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Arash Azin (A)

Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Ontario, Canada.

Houman Tahmasebi (H)

Faculty of Medicine, University of Toronto, Ontario, Canada.

Amanpreet Brar (A)

Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Ontario, Canada.

Sam Azin (S)

Department of Mathematics and Statistics, Queen's University, Kingston, Ontario, Canada.

Gary Ko (G)

Division of General Surgery, Department of Surgery, University of Toronto, Canada.

Andrea Covelli (A)

Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Ontario, Canada; Division of Surgical Oncology, Marvelle Koffler Breast Centre, Mount Sinai Health System, Toronto, Ontario, Canada.

Tulin Cil (T)

Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Ontario, Canada; Sprott Department of Surgery, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: tulin.cil@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH